Srivastava, A., Lusby, E.W. & Berns, K.I. Nucleotide sequence and organization of the adeno-associated virus 2 genome. J. Virol.45, 555–564 (1983). CASPubMedPubMed Central Google Scholar
Chiorini, J.A., Kim, F., Yang, L. & Kotin, R.M. Cloning and characterization of adeno-associated virus type 5. J. Virol.73, 1309–1319 (1999). CASPubMedPubMed Central Google Scholar
Davidson, B.L. et al. Recombinant adeno-associated virus type 2, 4, and 5 vectors: transduction of variant cell types and regions in the mammalian central nervous system. Proc. Natl. Acad. Sci. USA97, 3428–3432 (2000). ArticleCAS Google Scholar
Gao, G.P. et al. Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy. Proc. Natl. Acad. Sci. USA99, 11854–11859 (2002). ArticleCAS Google Scholar
Gao, G. et al. Adeno-associated viruses undergo substantial evolution in primates during natural infections. Proc. Natl. Acad. Sci. USA100, 6081–6086 (2003). ArticleCAS Google Scholar
Kay, M.A. et al. Evidence for gene transfer and expression of factor IX in haemophilia B patients treated with an AAV vector. Nat. Genet.24, 257–261 (2000). ArticleCAS Google Scholar
Manno, C.S. et al. AAV-mediated factor IX gene transfer to skeletal muscle in patients with severe hemophilia B. Blood101, 2963–2972 (2003). ArticleCAS Google Scholar
Moss, R.B. et al. Repeated adeno-associated virus serotype 2 aerosol-mediated cystic fibrosis transmembrane regulator gene transfer to the lungs of patients with cystic fibrosis: a multicenter, double-blind, placebo-controlled trial. Chest125, 509–521 (2004). Article Google Scholar
Samulski, R.J., Chang, L.S. & Shenk, T. Helper-free stocks of recombinant adeno-associated viruses: normal integration does not require viral gene expression. J. Virol.63, 3822–3828 (1989). CASPubMedPubMed Central Google Scholar
Berns, K.I. & Linden, R.M. The cryptic life style of adeno-associated virus. Bioessays17, 237–245 (1995). ArticleCAS Google Scholar
Xiao, X., Li, J. & Samulski, R.J. Efficient long-term gene transfer into muscle tissue of immunocompetent mice by adeno-associated virus vector. J. Virol.70, 8098–8108 (1996). CASPubMedPubMed Central Google Scholar
Halbert, C.L., Rutledge, E.A., Allen, J.M., Russell, D.W. & Miller, A.D. Repeat transduction in the mouse lung by using adeno-associated virus vectors with different serotypes. J. Virol.74, 1524–1532 (2000). ArticleCAS Google Scholar
Koeberl, D.D., Alexander, I.E., Halbert, C.L., Russell, D.W. & Miller, A.D. Persistent expression of human clotting factor IX from mouse liver after intravenous injection of adeno-associated virus vectors. Proc. Natl. Acad. Sci. USA94, 1426–1431 (1997). ArticleCAS Google Scholar
Snyder, R.O. et al. Persistent and therapeutic concentrations of human factor IX in mice after hepatic gene transfer of recombinant AAV vectors. Nat. Genet.16, 270–276 (1997). ArticleCAS Google Scholar
McCown, T.J., Xiao, X., Li, J., Breese, G.R. & Samulski, R.J. Differential and persistent expression patterns of CNS gene transfer by an adeno-associated virus (AAV) vector. Brain Res.713, 99–107 (1996). ArticleCAS Google Scholar
Lai, K., Kaspar, B.K., Gage, F.H. & Schaffer, D.V. Sonic hedgehog regulates adult neural progenitor proliferation in vitro and in vivo. Nat. Neurosci.6, 21–27 (2003). ArticleCAS Google Scholar
Erles, K., Sebokova, P. & Schlehofer, J.R. Update on the prevalence of serum antibodies (IgG and IgM) to adeno-associated virus (AAV). J. Med. Virol.59, 406–411 (1999). ArticleCAS Google Scholar
Moskalenko, M. et al. Epitope mapping of human anti-adeno-associated virus type 2 neutralizing antibodies: implications for gene therapy and virus structure. J. Virol.74, 1761–1766 (2000). ArticleCAS Google Scholar
Wobus, C.E. et al. Monoclonal antibodies against the adeno-associated virus type 2 (AAV-2) capsid: epitope mapping and identification of capsid domains involved in AAV-2-cell interaction and neutralization of AAV-2 infection. J. Virol.74, 9281–9293 (2000). ArticleCAS Google Scholar
Sun, J.Y., Anand-Jawa, V., Chatterjee, S. & Wong, K.K. Immune responses to adeno-associated virus and its recombinant vectors. Gene Ther.10, 964–976 (2003). ArticleCAS Google Scholar
Peden, C.S., Burger, C., Muzyczka, N. & Mandel, R.J. Circulating anti-wild-type adeno-associated virus type 2 (AAV2) antibodies inhibit recombinant AAV2 (rAAV2)-mediated, but not rAAV5-mediated, gene transfer in the brain. J. Virol.78, 6344–6359 (2004). ArticleCAS Google Scholar
Nguyen, J.B., Sanchez-Pernaute, R., Cunningham, J. & Bankiewicz, K.S. Convection-enhanced delivery of AAV-2 combined with heparin increases TK gene transfer in the rat brain. Neuroreport12, 1961–1964 (2001). ArticleCAS Google Scholar
Smith-Arica, J.R. et al. Infection efficiency of human and mouse embryonic stem cells using adenoviral and adeno-associated viral vectors. Cloning Stem Cells5, 51–62 (2003). ArticleCAS Google Scholar
Hughes, S.M., Moussavi-Harami, F., Sauter, S.L. & Davidson, B.L. Viral-mediated gene transfer to mouse primary neural progenitor cells. Mol. Ther.5, 16–24 (2002). ArticleCAS Google Scholar
Dong, J.Y., Fan, P.D. & Frizzell, R.A. Quantitative analysis of the packaging capacity of recombinant adeno-associated virus. Hum. Gene Ther.7, 2101–2112 (1996). ArticleCAS Google Scholar
Hermonat, P.L., Labow, M.A., Wright, R., Berns, K.I. & Muzyczka, N. Genetics of adeno-associated virus: isolation and preliminary characterization of adeno-associated virus type 2 mutants. J. Virol.51, 329–339 (1984). CASPubMedPubMed Central Google Scholar
Rabinowitz, J.E., Xiao, W. & Samulski, R.J. Insertional mutagenesis of AAV2 capsid and the production of recombinant virus. Virology265, 274–285 (1999). ArticleCAS Google Scholar
Girod, A. et al. Genetic capsid modifications allow efficient re-targeting of adeno- associated virus type 2. Nat Med. [published erratum appears in Nat. Med. 1999 Dec;5(12):1438] 5, 1052–1056 (1999). ArticleCAS Google Scholar
Shi, W., Arnold, G.S. & Bartlett, J.S. Insertional mutagenesis of the adeno-associated virus type 2 (AAV2) capsid gene and generation of AAV2 vectors targeted to alternative cell-surface receptors. Hum. Gene Ther.12, 1697–1711 (2001). ArticleCAS Google Scholar
Müller, O.J. et al. Random peptide libraries displayed on adeno-associated virus to select for targeted gene therapy vectors. Nat. Biotechnol.21, 1040–1046 (2003). Article Google Scholar
Perabo, L. et al. In vitro selection of viral vectors with modified tropism: the adeno-associated virus display. Mol. Ther.8, 151–157 (2003). ArticleCAS Google Scholar
Opie, S.R., Warrington, Jr., K.H., Jr., Agbandje-McKenna, M, Zolotukhin, S. & Muzyczka, N. Identification of amino acid residues in the capsid proteins of adeno- associated virus type 2 that contribute to heparan sulfate proteoglycan binding. J. Virol.77, 6995–7006 (2003). ArticleCAS Google Scholar
Walters, R.W. et al. Structure of adeno-associated virus serotype 5. J. Virol.78, 3361–3371 (2004). ArticleCAS Google Scholar
Xie, Q. et al. The atomic structure of adeno-associated virus (AAV-2), a vector for human gene therapy. Proc. Natl. Acad. Sci. USA99, 10405–10410 (2002). ArticleCAS Google Scholar
Stemmer, W.P. Rapid evolution of a protein in vitro by DNA shuffling. Nature370, 389–391 (1994). ArticleCAS Google Scholar
May, O., Nguyen, P.T. & Arnold, F.H. Inverting enantioselectivity by directed evolution of hydantoinase for improved production of l-methionine. Nat. Biotechnol.18, 317–320 (2000). ArticleCAS Google Scholar
Boder, E.T. & Wittrup, K.D. Yeast surface display for screening combinatorial polypeptide libraries. Nat. Biotechnol.15, 553–557 (1997). ArticleCAS Google Scholar
Daugherty, P.S., Chen, G., Iverson, B.L. & Georgiou, G. Quantitative analysis of the effect of the mutation frequency on the affinity maturation of single chain Fv antibodies. Proc. Natl. Acad. Sci. USA97, 2029–2034 (2000). ArticleCAS Google Scholar
Soong, N.W. et al. Molecular breeding of viruses. Nat. Genet.25, 436–439 (2000). ArticleCAS Google Scholar
Zhao, H., Giver, L., Shao, Z., Affholter, J.A. & Arnold, F.H. Molecular evolution by staggered extension process (StEP) in vitro recombination. Nat. Biotechnol.16, 258–261 (1998). ArticleCAS Google Scholar
Zolotukhin, S. et al. Recombinant adeno-associated virus purification using novel methods improves infectious titer and yield. Gene Ther.6, 973–985 (1999). ArticleCAS Google Scholar
Rabinowitz, J.E. et al. Cross-Packaging of a Single Adeno-Associated Virus (AAV) Type 2 Vector Genome into Multiple AAV Serotypes Enables Transduction with Broad Specificity. J. Virol.76, 791–801 (2002). ArticleCAS Google Scholar
Summerford, C. & Samulski, R.J. Membrane-associated heparan sulfate proteoglycan is a receptor for adeno-associated virus type 2 virions. J. Virol.72, 1438–1445 (1998). CASPubMedPubMed Central Google Scholar
Huttner, N.A. et al. Genetic modification of the adeno-associated virus type 2 capsid reduce the affinity and the neutralizating effects of human serum antibodies. Gene Ther.10, 2139–2147 (2003). ArticleCAS Google Scholar
Gao, G. et al. Clades of Adeno-associated viruses are widely disseminated in human tissues. J. Virol.78, 6381–6388 (2004). ArticleCAS Google Scholar
Hewat, E. & Blaas, D. in Antibodies in Viral Infections, vol. 260 (ed. Burton, D.R.) 29–44, (Springer-Verlag, Berlin, 2001). Book Google Scholar
Hansen, J., Qing, K., Kwon, H.J., Mah, C. & Srivastava, A. Impaired intracellular trafficking of adeno-associated virus type 2 vectors limits efficient transduction of murine fibroblasts. J. Virol.74, 992–996 (2000). ArticleCAS Google Scholar
Walters, R.W. et al. Binding of adeno-associated virus type 5 to 2,3-linked sialic acid is required for gene transfer. J. Biol. Chem.276, 20610–20616 (2001). ArticleCAS Google Scholar
Batard, P., Jordan, M. & Wurm, F. Transfer of high copy number plasmid into mammalian cells by calcium phosphate transfection. Gene270, 61–68 (2001). ArticleCAS Google Scholar
Kern, A. et al. Identification of a heparin-binding motif on adeno-associated virus type 2 capsids. J. Virol.77, 11072–11081 (2003). ArticleCAS Google Scholar